The potential of cell-based therapy for diabetes and diabetes-related vascular complications.

Abstract:

:Cell therapy has enormous potential for the treatment of conditions of unmet medical need. Cell therapy may be applied to diabetes mellitus in the context of beta cell replacement or for the treatment of diabetic complications. A large number of cell types including hematopoietic stem cells, mesenchymal stem cells, umbilical cord blood, conditioned lymphocytes, mononuclear cells, or a combination of these cells have been shown to be safe and feasible for the treatment of patients with diabetes mellitus. The first part of this review article will focus on the current perspective of the role of embryonic stem cells and inducible pluripotent stem cells for beta cell replacement and the current clinical data on cell-based therapy for the restoration of normoglycemia. The second part of this review will highlight the therapeutic role of MSCs in islet cells cotransplantation and the management of diabetes related vascular complications.

journal_name

Curr Diab Rep

journal_title

Current diabetes reports

authors

Liew A,O'Brien T

doi

10.1007/s11892-013-0469-6

subject

Has Abstract

pub_date

2014-03-01 00:00:00

pages

469

issue

3

eissn

1534-4827

issn

1539-0829

journal_volume

14

pub_type

杂志文章,评审
  • Pathophysiology of prediabetes.

    abstract::The term prediabetes refers to subjects with impaired fasting glucose and/or impaired glucose tolerance who are at increased risk for type 2 diabetes mellitus. Although both types of patients are at increased risk for developing type 2 diabetes mellitus and cardiovascular disease, they manifest distinct metabolic abno...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0032-7

    authors: Abdul-Ghani MA,DeFronzo RA

    更新日期:2009-06-01 00:00:00

  • Contrast-induced nephropathy: update with special emphasis on patients with diabetes.

    abstract::Contrast-induced nephropathy (CIN) continues to be a significant complication of the increasing use of iodinated contrast media. There have been few new insights into pathogenesis; despite multiple strategies aimed at prophylaxis, very few have proven efficacious. This article reviews our current knowledge regarding C...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0077-4

    authors: Solomon R

    更新日期:2007-12-01 00:00:00

  • Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

    abstract::In this review article, we first present a brief overview of the vascular and neural components of diabetic retinopathy. Next, the multifocal electroretinogram (mfERG) technique, which can map neuroretinal function noninvasively, is described. Findings in diabetic retinal disease using the mfERG are reviewed. We then ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0526-9

    authors: Bearse MA Jr,Ozawa GY

    更新日期:2014-01-01 00:00:00

  • Is the risk and nature of CVD the same in type 1 and type 2 diabetes?

    abstract::The incidence of both type 1 and type 2 diabetes is increasing globally, most likely explained by environmental changes, such as changing exposures to foods, viruses, and toxins, and by increasing obesity. While cardiovascular disease (CVD) mortality has been declining recently, this global epidemic of diabetes threat...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-013-0380-1

    authors: Duca L,Sippl R,Snell-Bergeon JK

    更新日期:2013-06-01 00:00:00

  • Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?

    abstract::Hypertension and diabetes are independent risk factors for both cardiovascular disease and renal complications. Coexistence of these comorbid conditions predisposes the patient to a much greater risk of progression to end-stage renal disease. Combined with the increased cardiovascular mortality, this has led to recent...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-002-0124-0

    authors: Newton CA,Raskin P

    更新日期:2002-12-01 00:00:00

  • Potential of glucose-lowering drugs to reduce cardiovascular events.

    abstract::Although a clear relationship exists between glycosylated hemoglobin and cardiovascular (CV) disease in individuals with type 2 diabetes mellitus (T2DM) in epidemiologic studies, data from prospective studies are less clear. Earlier prospective studies examining intensive glucose lowering suffered from a lack of stati...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0015-8

    authors: Zarich SW

    更新日期:2009-02-01 00:00:00

  • Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence.

    abstract:PURPOSE OF REVIEW:Currently, the diagnosis of gestational diabetes mellitus (GDM) lacks uniformity. Several controversies are still under debate, especially on the method of screening and diagnosis. This review focuses on recent literature and provides current evidence for the screening and diagnosis of GDM. RECENT FI...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1271-x

    authors: Kuo CH,Li HY

    更新日期:2019-12-04 00:00:00

  • The Charcot foot: medical and surgical therapy.

    abstract::Charcot neuro-osteoarthropathy (CN) is among the most devastating complications of neuropathy and now most commonly occurs in the feet of diabetic patients. Because it is relatively rare and because most patients and practitioners do not expect major bone pathology in the absence of significant pain, CN is often misdi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章

    doi:10.1007/s11892-008-0077-z

    authors: Ulbrecht JS,Wukich DK

    更新日期:2008-12-01 00:00:00

  • Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.

    abstract::Hyperglycemia and dyslipidemia are significant and independent risk factors for the vascular complications in patients with diabetes. They have been suggested to cause cardiovascular pathologic changes in diabetic states through the following molecular mechanisms: formation and accumulation of advanced glycation end p...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0034-z

    authors: Xu Y,He Z,King GL

    更新日期:2005-04-01 00:00:00

  • Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

    abstract::Metabolomics is the snapshot of all detectable metabolites and lipids in biological materials and has potential in reflecting genetic and environmental factors contributing to the development of complex diseases, such as type 1 diabetes. The progression to seroconversion to development of type 1 diabetes has been stud...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0820-9

    authors: Overgaard AJ,Kaur S,Pociot F

    更新日期:2016-12-01 00:00:00

  • Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutrition.

    abstract::Among the factors predisposing to type 2 diabetes in children, adolescents, and young adults, the health and behavior of both the mother and father are critical. Prevention and treatment of parental nutritional disorders (including obesity and malnutrition), promotion of breastfeeding, and avoidance of overfeeding of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-011-0246-3

    authors: Bartz S,Freemark M

    更新日期:2012-02-01 00:00:00

  • The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes.

    abstract:PURPOSE OF REVIEW:To evaluate the treatment of type 2 diabetes from a cardiologist's view. RECENT FINDINGS:A new era in the treatment of type 2 diabetes began for the cardiologist in 2015 with the publication of the EMPA-REG outcome trial finding a significant reduction in CV death with empagliflozin (oral sodium-gluc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1114-1

    authors: Chilton RJ,Gallegos KM,Silva-Cardoso J,Oliveros R,Pham S

    更新日期:2018-11-08 00:00:00

  • Nutrition Transition and the Global Diabetes Epidemic.

    abstract::Low- and middle-income countries (LMICs) face a rapid change in the nutrition transition toward increases in noncommunicable diseases. Underlying this transition are shifts in the agricultural system and the subsequent growth of the modern retail and food service sectors across all regions and countries, a change in t...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0631-4

    authors: Popkin BM

    更新日期:2015-09-01 00:00:00

  • Glucagon and type 2 diabetes: the return of the alpha cell.

    abstract::In normal physiology, glucagon from pancreatic alpha cells plays an important role in maintaining glucose homeostasis via its regulatory effect on hepatic glucose production. Patients with type 2 diabetes suffer from fasting and postprandial hyperglucagonemia, which stimulate hepatic glucose production and, thus, cont...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0555-4

    authors: Lund A,Bagger JI,Christensen M,Knop FK,Vilsbøll T

    更新日期:2014-12-01 00:00:00

  • Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry.

    abstract:PURPOSE OF REVIEW:Pancreas transplantation remains the best long-term treatment option to achieve euglycemia and freedom from insulin in patients with labile diabetes mellitus. It is an approved procedure for type 1 (T1DM), but it is still considered controversial for type 2 diabetes mellitus (T2DM). RECENT FINDINGS:T...

    journal_title:Current diabetes reports

    pub_type: 杂志文章

    doi:10.1007/s11892-017-0864-5

    authors: Gruessner AC,Laftavi MR,Pankewycz O,Gruessner RWG

    更新日期:2017-06-01 00:00:00

  • Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings?

    abstract::Suspicion that fructose-containing caloric sweeteners (FCCS) may play a causal role in the development of metabolic diseases has elicited intense basic and clinical research over the past 10 years. Prospective cohort studies converge to indicate that FCCS, and more specifically sugar-sweetened beverages (SSBs), consum...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0627-0

    authors: Tappy L,Lê KA

    更新日期:2015-08-01 00:00:00

  • PPAR-gamma agonists and diabetic nephropathy.

    abstract::Diabetic nephropathy is a clinical syndrome of albuminuria, declining glomerular filtration rate, and increased risk of cardiovascular disease. Multiple mechanisms have been implicated in its pathogenesis. Although current therapies appear to be effective, treatment of diabetic nephropathy remains suboptimal. This rev...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0057-5

    authors: Zhang Y,Guan Y

    更新日期:2005-12-01 00:00:00

  • Transitioning safely from intravenous to subcutaneous insulin.

    abstract::The transition from intravenous (IV) to subcutaneous (SQ) insulin in the hospitalized patient with diabetes or hyperglycemia is a key step in patient care. This review article suggests a stepwise approach to the transition in order to promote safety and euglycemia. Important components of the transition include evalua...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0595-4

    authors: Kreider KE,Lien LF

    更新日期:2015-05-01 00:00:00

  • Recovery of endocrine function after islet and pancreas transplantation.

    abstract::Long-standing type 1 diabetes (T1D) is associated with an absolute loss of endogenous insulin secretion (circulating C-peptide is undetectable) and a related defect in glucose counter-regulation that is often complicated by hypoglycemia unawareness, markedly increasing the risk for severe hypoglycemia. Both the transp...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0294-3

    authors: Rickels MR

    更新日期:2012-10-01 00:00:00

  • Benefit-to-Risk Balance of Weight Loss Interventions in Older Adults with Obesity.

    abstract:PURPOSE OF REVIEW:Obesity in the older adult is a burgeoning health epidemic that leads to increased morbidity, disability, and institutionalization. This review presents a brief overview of geriatric-specific consequences of obesity by highlighting the risks and benefits of intentional weight loss. RECENT FINDINGS:In...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1249-8

    authors: DiMilia PR,Mittman AC,Batsis JA

    更新日期:2019-11-04 00:00:00

  • The role of HNF4A variants in the risk of type 2 diabetes.

    abstract::Genes influence susceptibility to type 2 diabetes mellitus (T2DM), and both positional cloning and candidate gene approaches have been used to identify these genes. Linkage analysis has generated evidence for T2DM-predisposing variants on chromosome 20q in studies of Caucasians, Asians, and Africans, and fine-mapping ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0043-y

    authors: Mohlke KL,Boehnke M

    更新日期:2005-04-01 00:00:00

  • A review of adolescent adherence in type 1 diabetes and the untapped potential of diabetes providers to improve outcomes.

    abstract::Only 21 % of adolescents with type 1 diabetes (T1D) meet glycemic goals set forth by the American Diabetes Association. Adherence to therapy is a particular concern in this population, and the association between poor adherence and worsening glycemic control indicates that there is a critical need to improve adherence...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0621-6

    authors: Datye KA,Moore DJ,Russell WE,Jaser SS

    更新日期:2015-08-01 00:00:00

  • Epigenetics Variation and Pathogenesis in Diabetes.

    abstract:PURPOSE OF REVIEW:Great strides have recently been made in elucidating the role of genetic sequence variation in diabetes pathogenesis. Increasingly, studies are focusing on other factors that may contribute to the pathogenesis of diabetes, such as epigenetics, a term "traditionally" encompassing changes to the DNA tha...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1091-4

    authors: Zhang H,Pollin TI

    更新日期:2018-10-02 00:00:00

  • Machine Perfusion and the Pancreas: Will It Increase the Donor Pool?

    abstract:PURPOSE OF REVIEW:Pancreas transplantation enables complete patient independence from exogenous insulin administration and increases both patient survival and quality of life. Despite this, there has been a decline in pancreas transplantation for the past 20 years, influenced by changing donor demographics with more hi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1165-y

    authors: Hamaoui K,Papalois V

    更新日期:2019-07-10 00:00:00

  • National Strategies to Decrease the Burden of Diabetes and Its Complications.

    abstract::Comparative results from national strategies for diabetes care and prevention are needed to understand the impact and barriers encountered during the implementation process. Long-term outcomes are limited, but results on intermediate outcomes and processes of diabetes care measures are available from translational res...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0637-y

    authors: Haw JS,Tantry S,Vellanki P,Pasquel FJ

    更新日期:2015-09-01 00:00:00

  • Fatty liver, insulin resistance, and dyslipidemia.

    abstract::After recently being recognized as a feature of the metabolic syndrome, fatty liver has evolved as a key player in the pathogenesis of dyslipidemia. Development of nonalcoholic fatty liver disease comes from an imbalance between the influx and production of fatty acids and the use of fatty acids for oxidation or secre...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-008-0011-4

    authors: Adiels M,Taskinen MR,Borén J

    更新日期:2008-02-01 00:00:00

  • Endothelial dysfunction in human diabetes.

    abstract::In nondiabetic individuals, a poor response to an endothelium-dependent vasodilator in coronary vessels has been shown to increase the likelihood of a future cardiovascular event. Such prospective data are not as yet available in patients with type 1 or type 2 diabetes. However, consistent with the greatly increased c...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-002-0054-x

    authors: Mäkimattila S,Yki-Järvinen H

    更新日期:2002-02-01 00:00:00

  • Drugs on the horizon for diabesity.

    abstract::The coexistence of type 2 diabetes and obesity presents a complex therapeutic challenge. Future combination tablets may include agents to address diabetes and any accompanying cardiovascular risk factors. Injectable agents that improve glycemic control and facilitate weight loss have recently become available: the sol...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0093-1

    authors: Bailey CJ

    更新日期:2005-10-01 00:00:00

  • Family-Based Interventions Targeting Improvements in Health and Family Outcomes of Children and Adolescents with Type 1 Diabetes: a Systematic Review.

    abstract:PURPOSE OF REVIEW:A systematic review was conducted of family-based interventions to improve glycemic control, adherence, and psychosocial outcomes in children and adolescents with type 1 diabetes (T1D). Electronic databases were searched for randomized controlled trials (RCTs) published since the seminal Diabetes Cont...

    journal_title:Current diabetes reports

    pub_type: 杂志文章

    doi:10.1007/s11892-018-0981-9

    authors: Feldman MA,Anderson LM,Shapiro JB,Jedraszko AM,Evans M,Weil LEG,Garza KP,Weissberg-Benchell J

    更新日期:2018-02-19 00:00:00

  • What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

    abstract:PURPOSE OF REVIEW:We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titration needs, effects ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01347-3

    authors: Khan MS,Vaduganathan M

    更新日期:2020-10-11 00:00:00